BASHAR AL ASSAD’S UNCLE, ON TRIAL FOR FRAUD, HOSPITALIZED IN PARIS: SON

Middle East

Wed 18 December 2019:

Rifaat al-Assad, the uncle of the Syrian president, has been hospitalized in Paris while standing trial for money laundering, his son told AFP Tuesday.

“He has been in intensive care since last night (Monday)” at the American Hospital in Neuilly-sur-Seine west of Paris, Siwar al-Assad said.

Rifaat al-Assad suffered from a form of internal bleeding “and is not very well”. He will need to stay in intensive care for two or three days.

The younger brother of the late Syrian president Hafez al-Assad – father of the current president Bashar al-Assad – is standing trial in Paris for crimes allegedly committed between 1984 and 2016, including aggravated tax fraud and misappropriation of Syrian funds.

The charges relate to his vast property empire in France.

France’s national finance prosecutor called Monday for a four-year prison sentence and a 10-million-euro fine.

The prosecutor also called for the confiscation of all his real estate, valued at 90 million euros ($99.5 million).

Rifaat al-Assad, who divides his time between France and Britain, denies the charges.

The 82-year-old, dubbed the “Butcher of Hama” for allegedly commanding troops who put down an uprising in central Syria in 1982, has been under investigation in France since 2014.

Formerly Syria’s vice president, Assad left his home country in 1984 after mounting a failed coup against his brother Hafez, who led Syria from 1971 to 2000.

After he arrived in Europe, Rifaat al-Assad’s lavish lifestyle, four wives, and 16 children soon raised eyebrows.

His reported French fortune includes two Paris townhouses, one measuring 3,000 square meters, as well as a stud farm, a chateau, and 7,300 square meters of office space in Lyon.

He and his family also built up a huge portfolio of 507 properties in Spain, valued at around 695 million euros, Spanish legal documents show. All his properties in that country were seized by the authorities in 2017.

Assad’s trial opened on December 9.

Think your friends would be interested? Share this story!

Leave a Reply

Your email address will not be published. Required fields are marked *